Keith A. Goldan

SNDX

Keith A. Goldan serves as officer: Chief Financial Officer at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$241.3K

Net Position

Net Seller

$241.3K

Companies Traded

SNDX

Active Period

Jul 2025 – Feb 2026

5 total trades

Most Recent

Sell SNDX

Feb 10, 2026 · $71.7K

Keith A. Goldan's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

0 · $0.00

Sells

5 · $241.3K

Total Shares Bought

Total Shares Sold

12,280

SNDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 10, 2026↗	Sell	3,410	$21.03	$71.7K	140,429
Feb 9, 2026↗	Sell	3,410	$21.03	$71.7K	0
Feb 6, 2026↗	Sell	2,082	$20.62	$42.9K	143,839
Feb 4, 2026↗	Sell	2,082	$20.62	$42.9K	0
Jul 16, 2025↗	Sell	1,296	$9.29	$12.0K	0